Persistent depressive disorder is chronic depression lasting two years or more, with low mood on most days plus symptoms such as fatigue, poor self-esteem and hopelessness. It responds to antidepressants, typically SSRIs or SNRIs, and to psychotherapy, and the combination works best. Because the illness is chronic, treatment is measured in months, with most people seeing meaningful improvement within three to six months.
At Stedfast Psychiatry we take chronic depression seriously precisely because it is so easy to dismiss. We confirm the diagnosis, look for the major depressive episodes that often sit on top of it, and treat with the combination of medication and therapy that has the strongest evidence for chronic depression. Patients who have not responded to standard treatment can access Deep TMS at Palm Beach Gardens and Spravato at three of our Florida offices.
Symptoms of dysthymia
- Low or gloomy mood on most days for at least two years
- Low energy or fatigue
- Poor self-esteem and harsh self-criticism
- Difficulty concentrating or making decisions
- Hopelessness about the future
- Sleeping too little or too much
- Poor appetite or overeating
- No symptom-free stretch longer than two months
- Periods when symptoms deepen into a full major depressive episode
Causes and risk factors
Persistent depressive disorder shares its biology with major depression, including heritable risk, changes in serotonin and norepinephrine signaling, and altered stress-hormone regulation. What distinguishes it is often timing and chronicity: onset is frequently in childhood, adolescence or early adulthood, which is why many patients cannot recall a time without it.
Early adversity is a strong contributor. Childhood neglect, emotional abuse, loss of a parent and chronic family conflict are more common in people with chronic depression than in those with episodic depression. Chronic medical illness, chronic pain, long-term stress, social isolation and substance use maintain the condition once it starts. Temperament matters too: people high in negative affect and low in reward sensitivity are more vulnerable.
About 1.5 percent of US adults have persistent depressive disorder in a given year, and roughly half of those cases are classified as serious.
Source: National Institute of Mental Health, National Comorbidity Survey Replication
In a randomized trial of 681 adults with chronic depression, the combination of an antidepressant and CBASP produced an 85 percent response rate among completers, compared with 55 percent for medication alone and 52 percent for CBASP alone.
Source: Keller et al., New England Journal of Medicine, 2000
Roughly 75 percent of people with dysthymia experience at least one major depressive episode on top of it, a pattern known as double depression.
Source: American Psychiatric Association, DSM-5-TR
Onset is usually early: about half of cases begin before age 21.
Source: Klein et al., American Journal of Psychiatry
How we diagnose it at Stedfast Psychiatry
Chronic depression is often missed because the patient has adapted to it and does not report it as a problem. Your evaluation at Stedfast Psychiatry starts with a structured interview that maps your mood back through the years, asking specifically about the longest stretch you have felt well. We confirm at least two years of depressed mood on more days than not, with at least two accompanying symptoms, and no symptom-free period longer than two months. We also identify any major depressive episodes layered on top, a pattern called double depression, which is present in the majority of people with this diagnosis.
We use the PHQ-9 at every visit and, for chronic depression specifically, we screen for early trauma, bipolar spectrum features and personality traits that affect treatment planning. Medical contributors such as hypothyroidism, anemia, vitamin B12 or D deficiency, sleep apnea and medication side effects are ruled out with a history and labs including TSH, CBC and a metabolic panel.
Treatment options
Medication management
Antidepressants work for persistent depressive disorder, with SSRIs such as sertraline, escitalopram and fluoxetine, and SNRIs such as venlafaxine and duloxetine, as first-line choices. Bupropion suits people whose main complaints are fatigue and low motivation; mirtazapine helps when sleep and appetite are poor. Because the illness is chronic, we give each trial a full six to eight weeks at an adequate dose before judging it, and we expect gradual gains rather than a sudden lift. If one trial fails, we switch classes or augment with bupropion, a low-dose atypical antipsychotic such as aripiprazole, or lithium. Treatment usually continues for at least one to two years after response, and many patients choose to stay on medication longer because relapse rates are high when it is stopped early.
Psychotherapy
Cognitive behavioral analysis system of psychotherapy, known as CBASP, was designed specifically for chronic depression and is the therapy with the strongest evidence for it. It focuses on the interpersonal patterns that keep chronic depression going and teaches patients to analyze specific situations to get what they actually want from them. CBT, behavioral activation and interpersonal therapy are also effective. In a landmark trial of chronic depression, the combination of medication and CBASP produced response in about 85 percent of patients who completed treatment, compared with roughly half for either alone. Our therapists coordinate with your prescriber so that both parts of the plan move together.
Interventional options
When persistent depressive disorder has not responded to two or more adequate antidepressant trials, it meets the usual definition of treatment-resistant depression, and interventional options apply. Deep TMS, FDA-cleared for major depressive disorder, is offered at our Palm Beach Gardens office in a typical course of 36 sessions over six to nine weeks. Spravato (esketamine) nasal spray, FDA-approved for treatment-resistant depression, is offered at Boynton Beach, Palm Beach Gardens and Royal Palm Beach under the REMS program with two hours of in-office monitoring per dose. Both are covered by most insurance plans when criteria are met.
What to expect
Your first visit is a 45 to 60 minute psychiatric evaluation, in person or by video, that produces a diagnosis and a written plan. Because chronic depression responds gradually, we set expectations early: follow-ups every two to four weeks for the first two to three months, then every one to three months once you are improving. We track the PHQ-9 and ask about function, not just mood, because getting your energy, relationships and work back is the real goal. Telehealth follow-ups are available anywhere in Florida or South Carolina and help patients stay consistent over the months that chronic depression treatment requires.
When to seek help
If you cannot remember the last time you felt genuinely well, if people who know you describe you as always down, or if you have been treating low-grade depression as simply your personality, it is worth an evaluation. Chronic depression is treatable, and the longer it goes untreated the more it costs in relationships, work and health. If you have thoughts of death or suicide, call or text 988, go to the nearest emergency room, or call 911 if you are in immediate danger.
Specifiers and patterns
DSM-5 folded the older diagnoses of dysthymia and chronic major depression into a single category, persistent depressive disorder, and then uses specifiers to describe the pattern. With pure dysthymic syndrome means no major depressive episode in the past two years. With persistent major depressive episode means a full major episode has lasted the whole two years. With intermittent major depressive episodes describes the familiar double depression, where major episodes come and go on top of a chronic low baseline. Early onset, before age 21, is associated with more childhood adversity, more personality pathology and a somewhat slower response to treatment, though response still occurs.
Conditions that overlap or mimic it
Bipolar II disorder can present as chronic low mood with brief hypomanic periods that the patient does not report as a problem; we ask specifically about periods of unusually high energy and reduced sleep, because an antidepressant alone could worsen that condition. Generalized anxiety disorder often coexists and shares fatigue and poor concentration. Substance use, especially regular alcohol or cannabis, can create and sustain a chronic depressed state. Hypothyroidism, sleep apnea, chronic pain and some medications such as beta blockers and interferon produce persistent fatigue and low mood. Avoidant or dependent personality traits are common in long-standing dysthymia and are addressed in therapy rather than treated as a competing diagnosis.
Why chronic depression needs a different therapy
People who have been depressed since adolescence often never developed the habit of expecting their actions to affect outcomes. CBASP was built around this observation. Each session examines a specific recent interaction: what you wanted, what you did, what happened, and what would have had to change to get the desired result. Over time, patients learn that their behavior has consequences they can shape, which directly counters the learned helplessness at the center of chronic depression. The therapy also uses the therapeutic relationship itself to correct expectations formed by early hurtful relationships.
Daily structure and self-care
Chronic depression erodes routine, and rebuilding routine is treatment. Regular wake and sleep times, daily physical activity even at low intensity, scheduled contact with other people and a short list of valued activities each week form the behavioral backbone of recovery. Alcohol is a depressant and undermines both medication and sleep; cutting it back is one of the highest-yield changes a patient can make. Treating chronic pain, sleep apnea and other medical conditions removes maintaining factors.
Prognosis
Untreated, persistent depressive disorder tends to persist, with recovery rates of only about 10 percent per year in community samples. Treated with medication and therapy together, most patients achieve response and a substantial proportion reach full remission, and those gains are durable when treatment continues long enough. Relapse is more likely than in episodic depression, which is why we plan for maintenance from the start rather than treating a chronic illness as if it were a single episode.
Frequently asked questions
How is dysthymia different from major depression?
Major depression comes in episodes, each lasting at least two weeks, with symptoms severe enough to clearly disrupt daily life. Persistent depressive disorder is milder on any given day but lasts for years without a real break. Many people have both: a chronic low baseline with periodic major episodes layered on top. The chronic form is in some ways harder to treat because it has shaped how a person thinks about themselves, which is why therapy is so important alongside medication.
Is this just my personality?
It is a common belief, especially when symptoms started in childhood or adolescence, but persistent depressive disorder is an illness, not a temperament. The clearest evidence is that it responds to treatment: people who have been pessimistic, tired and self-critical for decades often describe feeling like a different person after six months of medication and therapy. If treatment reveals that you are naturally reserved or serious, that is fine. Low mood, hopelessness and exhaustion are not personality traits.
Which works better, medication or therapy?
For chronic depression, the combination clearly outperforms either one alone. In the largest trial, medication alone and CBASP alone each helped about half of patients, while the combination helped about 85 percent. Medication tends to improve energy, sleep and concentration first; therapy addresses the thinking patterns and interpersonal habits that chronic depression builds over years. If you can only do one, either is a reasonable start, and we add the other if progress stalls.
How long will treatment take?
Longer than for a single depressive episode. Expect the first signs of improvement at four to eight weeks, meaningful change at three to six months, and continued gains through the first year. Medication is usually continued for at least one to two years after you are well, because stopping early is the most common reason for relapse. Therapy is typically weekly for several months, then tapers. People who have been depressed for decades should expect a gradual process, not a switch.
Does insurance cover treatment for persistent depressive disorder?
Yes. It is a recognized diagnosis, and psychiatric evaluation, medication management and psychotherapy are covered by most major commercial plans and Medicare, which Stedfast Psychiatry accepts. Deep TMS and Spravato are covered by most plans when two or more antidepressant trials have not worked, and our staff handles prior authorization. For patients without insurance, a self-pay new-patient visit is $185.
Can I be treated by telehealth?
Yes. Evaluation, medication management and therapy for chronic depression all work well by video for patients anywhere in Florida or South Carolina, and telehealth removes a common barrier for people whose energy and motivation are low. In-person visits at any of our 13 offices are available when you prefer them. Deep TMS and Spravato require in-person visits at the offices that offer them.
Can children and teens have persistent depressive disorder?
Yes, and in young people the required duration is one year rather than two. Mood may show up as irritability rather than sadness, and the condition is often mistaken for a difficult phase or an attitude problem. Chronic depression in adolescence raises the risk of later major depression, substance use and academic problems, so early treatment matters. Our child and adolescent team evaluates and treats dysthymia with therapy first and medication when needed.
What if antidepressants have not worked for me?
Chronic depression is often undertreated rather than untreatable: doses too low, trials too short, or medication without therapy. We first make sure each trial has been adequate. If two or more adequate trials have failed, you meet the usual definition of treatment-resistant depression and may be a candidate for Deep TMS at Palm Beach Gardens or Spravato at Boynton Beach, Palm Beach Gardens or Royal Palm Beach. Augmentation strategies and CBASP are also options.
Where to get treatment for persistent depressive disorder (dysthymia)
Evaluation and treatment for persistent depressive disorder (dysthymia) is available at every Stedfast Psychiatry office and by video across Florida and South Carolina.
Related conditions
If you are thinking about harming yourself, call or text 988 now, or go to the nearest emergency room. This page is educational and does not replace an evaluation. Clinical content reviewed by Dr. David Husted, board-certified psychiatrist.